The specialty’s leading advocate, the Advocacy Council, is committed to bringing you news and insights on billing, coding and policy reform that directly affect your practice. Advocacy Insider, a recurring column in College Insider, keeps you in the loop.
Contact us at AdvocacyCouncil@acaai.org or 847-427-1200.
- Show all
- A/I Action
- Advocacy Alert
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- CA2PER Program
- College Advantage
- Committees
- Course
- COVID-19
- Disaster Resources
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Member benefit
- New Allergists
- News
- Opinion
- Pathways to Practice
- Patient Brochures
- Payer Education Campaign
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
- Women in Allergy
2026 HIPAA updates
This update provides members with a high-level overview with specific considerations for allergy and immunology practices.
Advocacy Council fights for you on Capitol Hill
Members of the ACAAI Advocacy Council were on Capitol Hill fighting for issues important to allergy practices last week.
New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
ACAAI applauds the latest expansion of GME slots
CMS announced the distribution of 400 new federally funded graduate medical education residency positions to hospitals across the country.
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
The Senate HELP Committee seeks answers on CPT codes and coverage policies
Sen. Cassidy’s Request for Information (RFI) asks for specific data on the AMA’s licensing and royalty fees.
Issue with federal BCBS coverage of Xolair for IgE-mediated food allergy
Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts plus at least two othe…
